CRISAFULLI, Ernesto
 Distribuzione geografica
Continente #
NA - Nord America 5.848
EU - Europa 4.832
AS - Asia 3.900
SA - Sud America 625
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 8
Totale 15.324
Nazione #
US - Stati Uniti d'America 5.734
RU - Federazione Russa 2.276
SG - Singapore 1.827
IT - Italia 1.004
CN - Cina 727
BR - Brasile 493
HK - Hong Kong 446
VN - Vietnam 382
FR - Francia 373
IE - Irlanda 310
DE - Germania 256
GB - Regno Unito 140
SE - Svezia 129
KR - Corea 128
BD - Bangladesh 98
NL - Olanda 96
FI - Finlandia 73
IN - India 67
AR - Argentina 65
CA - Canada 59
ID - Indonesia 34
IQ - Iraq 31
JP - Giappone 30
PL - Polonia 30
MX - Messico 28
ES - Italia 27
TR - Turchia 24
BE - Belgio 21
ZA - Sudafrica 20
BJ - Benin 19
UA - Ucraina 18
EC - Ecuador 17
NG - Nigeria 17
CL - Cile 15
PK - Pakistan 15
LT - Lituania 12
SA - Arabia Saudita 12
CO - Colombia 11
AT - Austria 10
EU - Europa 10
PH - Filippine 10
TG - Togo 10
UZ - Uzbekistan 10
JO - Giordania 9
MY - Malesia 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 7
KE - Kenya 7
PY - Paraguay 7
CZ - Repubblica Ceca 6
JM - Giamaica 6
MA - Marocco 6
AL - Albania 5
AU - Australia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EG - Egitto 5
BH - Bahrain 4
BY - Bielorussia 4
CR - Costa Rica 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
NO - Norvegia 4
NP - Nepal 4
RO - Romania 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
IR - Iran 3
MT - Malta 3
PT - Portogallo 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
DK - Danimarca 2
GT - Guatemala 2
IL - Israele 2
NC - Nuova Caledonia 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CU - Cuba 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GY - Guiana 1
IM - Isola di Man 1
Totale 15.313
Città #
Dallas 1.222
Singapore 864
Ashburn 845
Moscow 761
San Jose 733
Chandler 476
Hong Kong 444
Dublin 305
Verona 237
The Dalles 193
Jacksonville 184
Council Bluffs 178
Ho Chi Minh City 130
Beijing 114
Lawrence 108
Princeton 108
Los Angeles 101
Sindelfingen 100
Seattle 86
New York 85
Wilmington 84
Hanoi 75
Redondo Beach 70
Buffalo 62
Rome 53
São Paulo 51
Columbus 43
Milan 42
Santa Clara 42
Boardman 40
Munich 39
London 36
Redmond 35
Frankfurt am Main 34
Helsinki 34
Tokyo 28
Bologna 27
Xi'an 26
Ann Arbor 25
Turku 25
Warsaw 25
Falkenstein 24
Southend 24
Haiphong 23
Norwalk 23
Orem 23
Tianjin 21
Chicago 19
Cotonou 19
Amsterdam 18
Nuremberg 18
Abuja 17
Brussels 17
Da Nang 17
Denver 17
Guangzhou 17
Montreal 17
Dongguan 16
Chennai 15
Rio de Janeiro 15
San Francisco 15
Toronto 15
Atlanta 14
Brooklyn 14
Jinan 14
Lappeenranta 14
Paris 14
Phoenix 14
Stockholm 14
Poplar 13
City of London 12
Falls Church 12
Baghdad 11
Kent 11
Mexico City 11
Turin 11
Ankara 10
Curitiba 10
Jakarta 10
Lomé 10
Mumbai 10
Nanjing 10
New Delhi 10
Amman 9
Bari 9
Biên Hòa 9
Boston 9
Changsha 9
Hangzhou 9
Johannesburg 9
Naples 9
Trento 9
Belo Horizonte 8
Fairfield 8
Manchester 8
Seoul 8
Tashkent 8
Trieste 8
Brasília 7
Bắc Ninh 7
Totale 8.952
Nome #
Polmonite interstiziale con caratteristiche autoimmuni (IPAF) Interstitial pneumonia with autoimmune features (IPAF 679
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice 358
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 295
Role of Non-Invasive Ventilation in Elderly Patients: Therapeutic Opportunity or Medical Futility? An Updated Narrative Review 265
Nervous system: subclinical target of SARS-CoV-2 infection 186
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 182
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 181
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 179
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 176
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 176
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 175
Six-minute walk distance in healthy subjects: reference standards from a general population sample 165
Acute exacerbations of COPD: Risk factors for failure and relapse 156
Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: A Paradigmatic Case 153
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 152
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 151
Impact of the Visceral Adipose Tissue on Bone Quality in Patients with Untreated mild-to-severe Obstructive Sleep Apnoea 149
A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries 149
A shadow in the GOLD ABCD classification system: measurement of perception of symptoms in COPD 147
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 145
Impact of sex on circulating leukocytes composition in COPD patients 140
Bone Mineral Density in Mountain, Road Cyclists and Untrained Controls: Exercise, Diet and Hormones 139
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 139
Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial 131
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 127
Persisting exercise ventilatory inefficiency in subjects recovering from COVID-19. Longitudinal data analysis 34 months post-discharge 126
A High Degree of Dyspnea Is Associated With a Poor Maximum Exercise Capacity in Subjects With COPD With the Same Severity of Air-Flow Obstruction 126
Circulating eosinophil levels and lung function decline in stable chronic obstructive pulmonary disease: a retrospective longitudinal study 125
Beyond diagnosis: a narrative review of the evolving therapeutic role of medical thoracoscopy in the management of pleural diseases 125
Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients 125
Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD 124
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 124
Aerobic Intermittent Hypoxic Training Is Not Beneficial for Maximal Oxygen Uptake and Performance: A Systematic Review and Meta-Analysis 123
Are interstitial lung abnormalities associated with COPD? A nested case–control study 122
Assessment of severity of ICU-acquired pneumonia and association with etiology 122
Short-term efficacy of upper-extremity exercise training in patients with chronic airway obstruction: A systematic review 121
Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation 121
The Caliber of Segmental and Subsegmental Vessels in COVID-19 Pneumonia Is Enlarged: A Distinctive Feature in Comparison with Other Forms of Inflammatory and Thromboembolic Diseases 119
Exercise ventilatory inefficiency may be a relevant CPET-feature in COVID-19 survivors 119
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 116
A Practical Approach to Pneumothorax Management 115
Anthropometry in Special and Selective Conditions and Circumstances: Anthropometry as Measure of Risk in COPD Patients 115
Activity and analysis of costs in a dedicated weaning centre 114
Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry 113
Association between persistent dyspnea and psychological distress in COVID-19 survivors. A cross-sectional evaluation at 11 months after hospitalization 111
Feasibility and effectiveness of an educational program in Italian COPD patients undergoing rehabilitation 109
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 109
C-reactive protein at discharge, diabetes mellitus and ≥1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease 108
Innate immune reprogramming in circulating neutrophils of COPD patients 106
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 106
Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes 102
Endotracheal tubes for critically ill patients: An in vivo analysis of associated tracheal injury , mucociliary clearance, and sealing effi cacy 101
Do Patients with Bronchiectasis Have an Increased Risk of Developing Lung Cancer? A Systematic Review 100
Effect of α1 Antitrypsin Deficiency on Lung Volume Decline in Severe Asthmatic Patients Undergoing Biologic Therapy 100
Management of severe acute exacerbations of COPD: an updated narrative review 99
Exploring the efficacy and advancements of medical pleurodesis: a comprehensive review of current research 96
Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients 95
Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience 94
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 94
Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies 93
Factors associated with risk of death in hospitalized patients for exacerbation of chronic obstructive pulmonary disease: an updated scoping review 92
Cost-effectiveness of NIV applied to chronic respiratory failure 92
Endobronchial ultrasound: a pictorial essay 91
Cough, a vital reflex. mechanisms, determinants and measurements 91
Prevalence of Depression in Sarcoidosis: a comparison with asthmatic and healthy controls 90
COPD and the metabolic syndrome: An intriguing association 90
Endoscopic Technologies for Peripheral Pulmonary Lesions: From Diagnosis to Therapy 89
Autonomic nervous system alterations in patients with mild-to-moderate asthma: do not forget airflow obstruction! a lesson from COPD 89
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 88
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease 88
The Role of Medical Thoracoscopy with Talc Poudrage in Spontaneous, Iatrogenic, and Traumatic Pneumothorax: A Prolonged Experience of a Tertiary Care Center 87
Rehabilitation and supportive therapy in elderly patients with chronic obstructive pulmonary disease 87
Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation 87
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 87
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 86
Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis 86
Rehabilitation in COPD patients admitted for exacerbation 86
Long-term weight loss and maintenance in morbidly obese individuals with obstructive sleep apnea 85
Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma 85
Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study 84
Transthoracic Echocardiography and Chest Computed Tomography Arteriography in Patients with Acute Pulmonary Embolism: A Two-Year Follow-Up Study 84
Learning impact of education during pulmonary rehabilitation program. An observational short-term cohort study 84
Efficacy of standard rehabilitation in COPD outpatients with comorbidities 83
Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD 82
Home-centred physical fitness programme in morbidly obese individuals: A randomized controlled trial 82
Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD 81
Respiratory muscles training in COPD patients 81
Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: Comparison of costs 80
Measures of dyspnea in pulmonary rehabilitation 80
Impact of the visceral adipose tissue on bone quality in patients with untreated mild-to-severe obstructive sleep apnea 79
Pleuritis with pleural effusion due to a Bacillus megaterium infection 79
Predicting walking-induced oxygen desaturations in COPD patients: A statistical model 79
The role of the microbiome in childhood asthma 79
COPD 2017: A Year in Review 78
Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients 78
Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease 78
The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis 77
Subjective sleep quality during average volume assured pressure support (AVAPS) ventilation in patients with hypercapnic COPD: A physiological pilot study 77
Predicting poor prognosis in COPD patients: Looking for a lamp lit in the darkness of the night 77
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 76
Totale 12.167
Categoria #
all - tutte 57.932
article - articoli 56.226
book - libri 0
conference - conferenze 408
curatela - curatele 0
other - altro 253
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.045
Totale 115.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022581 18 142 4 22 13 20 6 74 30 26 88 138
2022/20231.583 132 115 230 246 130 380 12 104 140 21 42 31
2023/20241.002 47 73 139 141 63 126 48 92 10 40 127 96
2024/20252.767 196 103 79 420 131 126 108 152 431 172 265 584
2025/20269.189 586 365 1.434 1.334 2.026 540 777 548 685 436 199 259
Totale 15.663